𝔖 Bobbio Scriptorium
✦   LIBER   ✦

968 Pharmacogenetic Predictors for Treatment Outcome of Sunitinib in Metastatic Renal Cell Carcinoma Patients

✍ Scribed by H.S. Park; H. Kim; H. Park; W. Kwon; J. Lee; M. Lee; H. Kim; S. Shin; J. Ahn; S. Rha


Book ID
117663418
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
55 KB
Volume
48
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Prognostic nomogram for sunitinib in pat
✍ Robert J. Motzer; Ronald M. Bukowski; Robert A. Figlin; Thomas E. Hutson; M. Dro πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 3 views

## Abstract ## BACKGROUND. In a randomized, phase 3 trial, sunitinib demonstrated superior efficacy over interferon‐alfa as first‐line therapy in patients with metastatic clear‐cell renal cell carcinoma (RCC). On the basis of outcome data from that trial, the authors developed a nomogram for predi